References
- GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545–1602.
- Pandie S, Hellenberg D, Hellig F, et al. Approach to chest pain and acute myocardial infarction. S Afr Med J. 2016;106:239–245.
- Holmes DR. Jr. Cardiogenic shock: a lethal complication of acute myocardial infarction. Rev Cardiovasc Med. 2003;4:131–135.
- Daga LC, Kaul U, Mansoor A. Approach to STEMI and NSTEMI. J Assoc Physicians India. 2011;59 Suppl:19–25.
- Pang J, Zhang Z, Zheng T, et al. The clinical, angiographic and prognosis characteristics of elderly patients with acute ST-segment elevation myocardial infarction-the first elderly STEMI population study in northwest of China. Int J Cardiol. 2015;179:326–328.
- Le Moullec JM, Jullienne A, Chenais J, et al. The complete sequence of human preprocalcitonin. FEBS Lett. 1984;167:93–97.
- Maruna P, Nedelníková K, Gürlich R. Physiology and genetics of procalcitonin. Physiol Res. 2000;49 Suppl 1:57–61.
- Conlon JM, Grimelius L, Thim L. Structural characterization of a high-molecular-mass form of calcitonin [procalcitonin-(60-116)-peptide] and its corresponding N-terminal flanking peptide [procalcitonin-(1-57)-peptide] in a human medullary thyroid carcinoma. Biochem J. 1988;256:245–250.
- Charles PE, Ladoire S, Aho S, et al. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria. BMC Infect Dis. 2008;8:38.
- Sponholz C, Sakr Y, Reinhart K, et al. Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care. 2006;10:145.
- Sentürk T, Cordan J, Baran I, et al. Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease. Acta Cardiol. 2007;62:135–141.
- Kelly D, Khan SQ, Dhillon O, et al. Procalcitonin as a prognostic marker in patients with acute myocardial infarction. Biomarkers. 2010;15:325–331.
- Ataoğlu HE, Yilmaz F, Uzunhasan I, et al. Procalcitonin: a novel cardiac marker with prognostic value in acute coronary syndrome. J Int Med Res. 2010;38:52–61.
- Picariello C, Lazzeri C, Attanà P, et al. The impact of admission procalcitonin on prognosis in acute coronary syndromes: a pilot study. Biomarkers. 2012;17:56–61.
- Bektas F, Soyuncu S, Gunduz I, et al. The value of procalcitonin, a novel inflammatory marker, in the diagnosis of myocardial infarction and evaluation of acute coronary syndrome patients. J Emerg Med. 2011;41:524–530.
- Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation. 2012;126:2020–2035.
- Braunwald E, Antman EM, Beasley JW, American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina), et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction–2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation. 2002;106:1893–1900.
- Killip T, 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967;20:457–464.
- Muhadi Nasution SA, Putranto R, et al. The ability of detecting heart rate variability with the photoplethysmography to predict major adverse cardiac event in acute coronary syndrome. Acta Med Indones. 2016;48:48–53.
- Jones AE, Fiechtl JF, Brown MD, et al. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med. 2007;50:34–41.
- Meisner M, Tschaikowsky K, Palmaers T, et al. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care. 1999;3:45–50.
- Kafkas N, Venetsanou K, Patsilinakos S, et al. Procalcitonin in acute myocardial infarction. Acute Card Care. 2008;10:30–36.
- O'Connor CM, Starling RC, Hernandez AF, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med. 2011;365:32–43.
- Vasatova M, Pudil R, Horacek JM, et al. Current applications of cardiac troponin T for the diagnosis of myocardial damage. Adv Clin Chem. 2013;61:33–65.